Inogen, Inc (NASDAQ:INGN) is reporting third quarter earnings results on Wednesday 4th November 2020, after market close.
The consensus estimates from Thomson Reuters are loss of $ 0.02 per share.
For the full year, analysts predict revenues of $ 312.72 million, while looking forward to loss of $ 0.08 per share.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 385.00 million ~ $ 400.00 million
Click Here For More Historical Outlooks Of Inogen, Inc
Previous Quarter Performance
Inogen, Inc announced income for the second quarter of $ 0.12 per share, from the revenue of $ 71.69 million. The quarterly earnings 73.33 percent while revenues dropped 29.06 percent compared with the same quarter last year.
Street analysts expected Inogen, Inc to report loss of $ 0.08 per share on revenue of $ 79.96 million for the second quarter. The bottom line results beat street analysts by $ 0.2 or 250.00 percent, at the same time, top line results fell short of analysts by $ 8.27 million or 10.34 percent.
Stock Performance
Shares of Inogen, Inc traded up $ 0.79 or 2.77 percent on Tuesday, reaching $ 29.28 with volume of 174.50 thousand shares. Inogen, Inc has traded high as $ 29.52 and has cracked $ 28.10 on the downward trend
According to the previous trading day, closing price of $ 29.28, representing a 7.23 % increase from the 52 week low of $ 26.57 and a 62.95 % decrease over the 52 week high of $ 76.89.
The company has a market capital of $ 646.09 million and is part of the Healthcare sector and Medical Devices industry.
Conference Call
Inogen, Inc will be hosting a conference call at 4:30 PM eastern time on 4th November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.inogen.com
Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; and Inogen At Home stationary oxygen concentrators, as well as related accessories.
